Skip to main content

Collegium Pharmaceutical, Inc

COLL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001267565

No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 279 institutions reported holding it in 13F filings for Q2 2026, worth $1.42B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Collegium Pharmaceutical, Inc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of COLL: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders178175−3
Shares39.2M38.6M−600.4K (−1.5%)
Value$843.5M$865.2M+$21.8M (+2.6%)

New holders (17)

Institutions that held Collegium Pharmaceutical, Inc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to COLL in Q3 2023
InstitutionSharesValue% of portfolio
Uniplan Investment Counsel, Inc.102,616$2.32M0.18%
Cubist Systematic Strategies, LLC78,155$1.75M0.02%
SummerHaven Investment Management, LLC33,666$752.4K0.55%
Wedge Capital Management L L P28,216$630.6K0.01%
Royce & Associates LP21,230$474.5K0.00%
Cornercap Investment Counsel Inc21,043$470.3K0.09%
Illinois Municipal Retirement Fund19,468$435.0K0.01%
Comerica Bank16,101$359.9K0.00%
Dark Forest Capital Management LP14,208$317.5K0.03%
Campbell & CO Investment Adviser LLC12,871$287.7K0.03%
SG Americas Securities, LLC9,905$221.0K0.00%
Engineers Gate Manager LP9,840$219.9K0.01%
Versor Investments LP9,263$207.0K0.04%
Point72 Middle East FZE9,142$204.3K0.01%
Vestcor Inc2,588$58.0K0.00%
Point72 Asset Management, L.P.952$21.3K0.00%
Steward Financial Group LLC37$00.00%

Sold out (20)

Institutions that held Collegium Pharmaceutical, Inc at the end of Q2 2023 and filed for Q3 2023 without it.